Amoy Diagnostics Co.,Ltd.’s Net Profit Rose 7.5% in First Quarter of 2023

Amoy Diagnostics Co.,Ltd. (厦门艾德生物医药科技股份有限公司) (300685.SZ) reported a net profit of 57.3 million yuan in the first quarter of 2023, up 7.5% year-on-year.

Meanwhile, the company posted 195.2 million yuan in revenue, down 5.3% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 126.7 million yuan in total liabilities, with a liability-to-asset ratio of 7.6%.